Navigation Links
SpineSmith Partners and Celling Technologies Hire New VP of Research and Development
Date:7/1/2010

AUSTIN, Texas, July 1 /PRNewswire/ -- SpineSmith Partners and Celling Technologies hired Brian Burkinshaw as Vice President of Research and Development, strengthening the company's position as an industry leader in adult stem cell technology innovations.

Burkinshaw will lead SpineSmith's product development efforts through the collaboration of the company's mechanical engineering department and Celling Technologies' team of scientists.  These teams work closely with surgeons to develop unique products for the evolving market of regenerative medicine.  Burkinshaw has over 30 years of experience in multiple medical device markets as a design engineer and in senior executive positions.  Burkinshaw's experience includes the evaluation and development of technologies for venture capital investment, medical device design and development, project management, business development, product commercialization, patent prosecution, and operations.  The company believes that the emerging field of regenerative medicine will change the landscape of medicine and require thought leaders capable of developing therapies and devices.  Burkinshaw's background with both traditional orthopedic companies and emerging biologic companies provides the creative foundation to merge the fields.  

"Brian is a natural leader and brings a range of experiences to the company, all of which will reinforce our position as an innovator in adult stem cell technologies," said Mike Gluk, Chief Operating Officer of SpineSmith. "Brian's market knowledge and sense of innovation will enhance our collaborative approach to the development of devices and therapies."  

Burkinshaw joins a recently recruited team of seasoned medical professionals that will guide SpineSmith and Celling Technologies through the next phase of growth of their newest product portfolio: Autologous Regenerative Therapies of the 21st Century (ART-21).  Mike Gluk (CFO/COO), Dr. Jim Poser (VP of Regenerative Medicine), Kevin Were (VP of Business Development) and Laura LeBoeuf  (VP of Quality & Regulatory Affairs) collectively provide the experience and talent to research and develop opportunities in the field of regenerative medicine.  Together the team will work on scientific research, product development and regulatory approvals that will deliver cost-effective applications and devices focused on point-of-care adult stem cell therapies across many disciplines.  

The companies will launch two new innovative products in the coming months with a focus on regenerative medicine.  

"I believe the future of medicine will rely heavily on biologics and the focus of these companies is to research and develop those opportunities.  The scientific team at Celling Technologies provides a unique and timely foundation for product development through the research of adult autologous stem cells and their potential applications in spine, orthopedics, trauma, plastics and related disorders," said Burkinshaw.  

About SpineSmith Partners, LP

SpineSmith Partners, LP designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. SpineSmith takes a different approach from other companies, utilizing a collaborative approach between scientists, engineers and spine surgeons. It's this unique approach that gives spine surgeons the ability to directly impact the direction of their product portfolio, ensuring applicability and achieving the highest standards of patient care.

Founded in Austin, Texas, in 2006, SpineSmith originated as a think tank to enable surgeon investors to have direct input into the design and distribution of spine technology. www.spinesmithusa.com

About Celling Technologies

Celling Technologies, a SpineSmith Partners company, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine.  Celling Technologies' product offering focuses on autologous adult stem cell therapy and the devices and services that complement these procedures.  www.cellingtechnologies.com


'/>"/>
SOURCE Celling Technologies; SpineSmith Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
2. JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute
3. Ethicon Endo-Surgery Extends Research Partnership with $13.5 Million Grant to University of Cincinnati
4. LifeNet Health and Salvin Dental Specialties Announce Partnership
5. Xacore Partners With ESSE, Headed by Retired Army Four Star General, to Tackle Military Hearing Loss
6. Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products
7. Southern California Cell Company Partners With Northern California Life Science Research Technology Company for Developing Human Derived Disease Specific iPS Cell Lines
8. Simulated Surgical Systems, LLC Partners to Bring Simulation Advances to Surgical Training
9. Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course
10. St. Jude Medical and iRhythm Technologies Enter into Partnership to Co-Market Novel Cardiac Rhythm Monitor
11. Carrot Medical Partners with MAVIG GmbH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Frontier Pharma: ... Commercializing First-in-Class Innovation Chronic Obstructive ... with chronic inflammation of the airways and lungs. ... symptoms make the disease one of the leading ... death in the world. COPD is linked to ...
(Date:2/4/2016)... Feb. 4, 2016  Aethlon Medical, Inc. (Nasdaq: ... biofiltration devices to treat life-threatening diseases, today announced ... ended December 31, 2015. --> ... set forth in our last quarterly call, we ... our long-term objective to establish the Aethlon Hemopurifier® ...
(Date:2/4/2016)... , Feb. 4, 2016  Blueprint Medicines ... discovering and developing highly selective investigational kinase medicines ... the appointment to its board of directors of ... with nearly 30 years of industry-related experience. ... of Blueprint Medicines. "Lonnel,s strong strategic experience developing ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Looking for a last-minute Valentine’s ... the tips of your toes. Foot massage, whether administered by a professional masseuse or ... relaxation. The American Board of Multiple Specialties in Podiatry (ABMSP) has taken ...
(Date:2/5/2016)... Rafael, CA (PRWEB) , ... February 05, 2016 , ... ... with ChildLight Yoga Studio in Dover, NH to direct high-performance kids yoga training. ChildLight ... New Hampshire’s seacoast, just one hour from Boston. , ChildLight Yoga Studio founder Lisa ...
(Date:2/5/2016)... ... 05, 2016 , ... Give To Cure today announced that it ... to Give To Cure’s campaign that is crowdfunding clinical trials to help find cures ... payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... In sleep, ... form as a dream. A hallmark feature of patients with eating disorders is significant ... The eating disorder behaviors and obsessions are regarded as maladaptive means for coping with ...
Breaking Medicine News(10 mins):